Acarbose and Rabeprazole drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Acarbose (acarbose) and Rabeprazole (rabeprazole sodium). Common drug interactions include sudden hearing loss among females and pyrexia among males.

The phase IV clinical study analyzes what interactions people have when they take Acarbose and Rabeprazole. It is created by eHealthMe based on reports of 53 people who take the same drugs from the FDA, and is updated regularly.

What is Acarbose?

Acarbose has active ingredients of acarbose. It is often used in diabetes. eHealthMe is studying from 4,605 Acarbose users. Check the latest studies of Acarbose.

What is Rabeprazole?

Rabeprazole has active ingredients of rabeprazole sodium. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 31,689 Rabeprazole users. Check the latest studies of Rabeprazole.



On Jul, 07, 2026

53 people who take Acarbose and Rabeprazole together, and have interactions are studied.

Acarbose and Rabeprazole drug interactions.

What are the common drug interactions of Acarbose and Rabeprazole, by gender? *:

female:

  1. Sudden hearing loss
  2. Tinnitus (a ringing in the ears)
  3. Abdominal distension
  4. Abdominal mass (localized enlargement or swelling in the human abdomen)
  5. Anaemia (lack of blood)
  6. Angina pectoris (chest pain due to ischemia of the heart muscle)
  7. Anorexia (eating disorder characterized by immoderate food restriction and irrational fear of gaining weight)
  8. Arthritis (form of joint disorder that involves inflammation of one or more joints)
  9. Ascites (accumulation of fluid in the abdominal cavity)
  10. Autonomic nervous system imbalance (autonomic nervous system is of net equal emphasis)

male:

  1. Pyrexia (fever)
  2. Blood albumin decreased
  3. Nasopharyngitis (inflammation of the nasopharynx)
  4. Hypoproteinaemia (too little prolactin circulating in the blood)
  5. Cystitis haemorrhagic (blood in the urine and painful voiding)
  6. Dysuria (painful or difficult urination)
  7. Fatigue (feeling of tiredness)
  8. Gastritis (inflammation of stomach)
  9. Haematuria (presence of blood in urine)
  10. Hypernatraemia (an abnormally high plasma concentration of sodium ions)

What are the common drug interactions of Acarbose and Rabeprazole, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Bacteriuria (presence of bacteria in urine)
  2. Blood glucose increased
  3. Glucose urine present
  4. Hypochloraemia (electrolyte disturbance in which there is an abnormally low level of the chloride ion in the blood)
  5. Lymphadenopathy (disease or enlargement of lymph nodes)
  6. Nasopharyngitis (inflammation of the nasopharynx)
  7. Platelet count increased

30-39:

  1. Sinusitis (inflammation of sinus)

40-49:

  1. Anxiety
  2. Chronic kidney disease
  3. Dizziness
  4. Emotional distress
  5. Fatigue (feeling of tiredness)
  6. Nephrolithiasis (calculi in the kidneys)
  7. Pain
  8. Renal impairment (severely reduced kidney function)

50-59:

  1. Cystitis haemorrhagic (blood in the urine and painful voiding)
  2. Dysuria (painful or difficult urination)
  3. Gastritis (inflammation of stomach)
  4. Haematuria (presence of blood in urine)
  5. Hypernatraemia (an abnormally high plasma concentration of sodium ions)
  6. Interstitial lung disease
  7. Periodontitis (inflammation of the tissue around the teeth)
  8. Tenderness (pain or discomfort when an affected area is touched)
  9. Upper respiratory tract infection
  10. Body temperature increased

60+:

  1. Pyrexia (fever)
  2. Malaise (a feeling of general discomfort or uneasiness)
  3. Abdominal pain upper
  4. Adverse reaction
  5. Alopecia (absence of hair from areas of the body)
  6. Arteriosclerosis coronary artery (thickening and hardening of arteries- coronary artery)
  7. Arthralgia (joint pain)
  8. Asthenia (weakness)
  9. Blood glucose increased
  10. Chronic gastritis (long lasting infection of stomach lining)

What are the existing conditions these people have? *

  1. High Blood Pressure: 16 people, 30.19%
  2. Blood Glucose Increased: 9 people, 16.98%
  3. Hypogammaglobulinaemia (an abnormally low concentration of gamma globulin in the blood and increased risk of infection): 9 people, 16.98%
  4. Inflammation: 7 people, 13.21%
  5. Blood Uric Acid Increased: 6 people, 11.32%
  6. Productive Cough: 6 people, 11.32%
  7. Haemostasis (stopping of bleeding): 5 people, 9.43%
  8. Gastric Disorder (disease of stomach): 5 people, 9.43%
  9. Fever: 5 people, 9.43%
  10. Cough: 5 people, 9.43%

* Approximation only. Some reports may have incomplete information.

Do you take Acarbose and Rabeprazole?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Acarbose and Rabeprazole:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Acarbose:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Rabeprazole:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Acarbose and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Rabeprazole and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on acarbose and rabeprazole sodium (the active ingredients of Acarbose and Rabeprazole, respectively), and Acarbose and Rabeprazole (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: